#

+1 (917) 893 7512

  • #
  • #
  • #
#
Global Biologics Market Report, Biologics Market: Size, Trends & Forecast (2018-2022)

Global Biologics Market: Size, Trends & Forecast (2018-2022)

Publish Date:Feb 2018
No. of Pages:91

Format : Adobe Reader (PDF) Instant delivery

US$ 900.00

Scope of the Report

The report entitled “Global Biologics Market: Size, Trends & Forecast (2018-2022)”, provides an in-depth analysis of the global biologics market with description of market sizing and growth. The analysis includes market by value, by segment and by region. It also provides a detailed analysis of biologics market in terms of manufacturing process, product-category and therapeutic areas as well.

The report includes a brief regional analysis of North America, Europe and China with their actual and forecasted market size. North America has the largest stake in the global biologics market over the years and is expected to maintain its position in the upcoming years also. Among the Asia countries, China is the largest market and has the potential to grow steadily over the forecasted period.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Abbvie Inc., Samsung Electronics (Samsung Biologics), F. Hoffmann La Roche and Amgen Inc. are some of the key players operating in the global biologics market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the respective companies are provided.

Company Coverage

Abbvie Inc.
Samsung Electronics (Samsung Biologics)
F. Hoffmann La Roche
Amgen Inc.

Regional Coverage

North America
Europe
China

Executive Summary

Pharmaceutical industry is engaged in the discovery, manufacturing and marketing of pharmaceutical drugs such as legal drugs, vaccines, biologics and a large number of medical devices such as infusion pump, pacemakers, prosthetics, implantable defibrillators etc. Pharmaceutical drugs and devices are subjected to various laws and regulations governing their patent, safety, and efficacy. On an elementary level pharmaceutical drugs are broadly classified into two categories: small molecules (non-biologics) and large molecules (biologics).

Large molecules are mostly made of cells or other living organisms and are used to produce therapeutic proteins or biological molecules. Drugs made up of large molecules are popularly known as biotech drugs, biologics or biopharmaceuticals. The major biologics blockbusters currently available in the market are Humira, Remicade, Enbrel, Avastin and Herceptin.

The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2018-2022, particularly due to increasing biologics approval and growing incidence of chronic conditions among the aging population. The global biologics market is supported by various growth drivers such as increased availability of advanced diagnostics, raising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases, advancement in healthcare & biotechnology, etc. Yet the market faces some challenges which are obstructing the growth of the market. Some of the major challenges faced by the industry are: high cost of biologics, lack of oral absorption, complex regulatory approval etc.

1. Executive Summary

2. Introduction

2.1 Pharmaceutical Industry: An Overview
2.1.1 Segmentation of Pharmaceutical Industry (Drugs) 

2.2 Biologics: An Overview
2.2.1 Biologics Definition
2.2.2 Biologics Medical Use
2.2.3 Difference between Chemical Drugs and Biologics
2.2.4 Key Biologics Product US/EU Expiry Date

2.3 Biologics Manufacturing Process
2.3.1 Biologics Manufacturing Process
2.4 Biologics Product-Category
2.4.1 Biologics Product-Category

3. Global Market Analysis

3.1 Global Pharmaceuticals Market Analysis
3.1.1 Global Pharmaceuticals Market by Value
3.1.2 Global Pharmaceuticals Market by Segments

3.2 Global Biologics Market Analysis 
3.2.1 Global Biologics Market by Value
3.2.2 Global Biologics Manufacturing Market by Value
3.2.3 Global Biologics Market by Product-Category
3.2.4 Global Biologics Market by Therapeutic Areas
3.2.5 Global Biologics Market by Region
3.2.6 Global Biologics Market Growth Outlook by Region
3.2.7 Global Biologics Manufacturing Market by Segments

3.3 Global Biologics Manufacturing Market: Segment Analysis
3.3.1 Global Bio CMO Market by Value
3.3.2 Global Biologics In-House Market by Value

3.4 Global Biologics Market: Product Analysis
3.4.1 Global Biologics Monoclonal Antibodies Market by Value
3.4.2 Global Biologics Recombinant Protein Market by Value
3.4.3 Global Biologics Vaccines Market by Value
3.4.4 Global Biologics Regenerative Medicines Market by Value

3.5 Global Biologics Market: Therapeutic Areas Analysis
3.5.1 Global Biologics Inflammatory Market by Value
3.5.2 Global Biologics Oncology and Immunomodulatory Market by Value
3.5.3 Global Biologics Endocrine Market by Value
3.5.4 Global Biologics Anti-Infectives Market by Value

4. Regional Analysis

4.1 North America Biologics Market Analysis
4.1.1 North America Biologics Market by Value

4.2 Europe Biologics Market Analysis
4.2.1 Europe Biologics Market by Value

4.3 China Biologics Market Analysis
4.3.1 China Biologics Market by Value

5. Market Dynamics

5.1 Growth Drivers 
5.1.1 Increasing Biologics Approvals
5.1.2 Raising Autoimmune Disease Prevalence
5.1.3 Growing Number of Biosimilars
5.1.4 Preference of Biologics over Small Molecules

5.2 Challenges
5.2.1 High Cost
5.2.2 Lack of Oral Absorption
5.2.3 Operational and Technological Challenges 
5.2.4 Complex Regulatory Approval

5.3 Market Trends
5.3.1 Increasing Focus on New Therapeutic Areas
5.3.2 Potential Biologics Blockbusters
5.3.3 Advancement in Healthcare and Biotechnology
5.3.4 Commercial Success of Biotech Products
5.3.5 Reimbursement Policy

6. Competitive Landscape
6.1 Global Biologics Market by Players/Drugs

7. Company Profiles

7.1 Abbvie Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy

7.2 Samsung Electronics (Samsung Biologics)
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy

7.3 F. Hoffmann La Roche 
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

7.4 Amgen Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
Figure 1: History of Pharmaceutical Industry
Figure 2: Pharmaceutical Industry Segments
Figure 3: Biologics Manufacturing Process
Figure 4: Biologics Product-Category
Figure 5: Global Pharmaceuticals Market by Value; 2012-2017 (US$ Billion)
Figure 6: Global Pharmaceuticals Market by Value; 2018-2022E (US$ Billion)
Figure 7: Global Pharmaceuticals Market by Segments; 2017
Figure 8: Global Biologics Market by Value; 2012-2017 (US$ Billion)
Figure 9: Global Biologics Market by Value; 2018-2022E (US$ Billion)
Figure 10: Global Biologics Manufacturing Market by Value; 2013-2017 (US$ Billion)
Figure 11: Global Biologics Manufacturing Market by Value; 2018-2022E (US$ Billion)
Figure 12: Global Biologics Market by Product-Category; 2017
Figure 13: Global Biologics Market by Therapeutic Areas; 2017
Figure 14: Global Biologics Market by Region; 2017
Figure 15: Global Biologics Market Growth Outlook (CAGR) by Region; 2016-2021 (%)
Figure 16: Global Biologics Manufacturing Market by Segments; 2017
Figure 17: Global Bio CMO Market by Value; 2012-2017 (US$ Billion)
Figure 18: Global Bio CMO Market by Value; 2018-2022E (US$ Billion)
Figure 19: Global Biologics In-House Market by Value; 2015-2017 (US$ Billion)
Figure 20: Global Biologics In-House Market by Value; 2018-2022E (US$ Billion)
Figure 21: Global Biologics Monoclonal Antibodies Market by Value; 2015-2017 (US$ Billion)
Figure 22: Global Biologics Monoclonal Antibodies Market by Value; 2018-2022E (US$ Billion)
Figure 23: Global Biologics Recombinant Protein Market by Value; 2015-2017(US$ Billion)
Figure 24: Global Biologics Recombinant Protein Market by Value; 2018-2022E (US$ Billion)
Figure 25: Global Biologics Vaccines Market by Value; 2015-2017 (US$ Billion)
Figure 26: Global Biologics Vaccines Market by Value; 2018-2022E (US$ Billion)
Figure 27: Global Biologics Regenerative Medicine Market by Value; 2015-2017 (US$ Billion)
Figure 28: Global Biologics Regenerative Medicine Market by Value; 2018-2022E (US$ Billion)
Figure 29: Global Biologics Inflammatory Market by Value; 2015-2017 (US$ Billion)
Figure 30: Global Biologics Inflammatory Market by Value; 2018-2022E (US$ Billion)
Figure 31: Global Biologics Oncology and Immunomodulatory Market by Value; 2015-2017 (US$ Billion)
Figure 32: Global Biologics Oncology and Immunomodulatory Market by Value; 2018-2022E (US$ Billion)
Figure 33: Global Biologics Endocrine Market by Value; 2015-2017 (US$ Billion)
Figure 34: Global Biologics Endocrine Market by Value; 2018-2022E (US$ Billion)
Figure 35: Global Biologics Anti-Infectives Market by Value; 2015-2017 (US$ Billion)
Figure 36: Global Biologics Anti-Infectives Market by Value; 2018-2022E (US$ Billion)
Figure 37: North America Biologics Market by Value; 2016-2017 (US$ Billion)
Figure 38: North America Biologics Market by Value; 2018-2022E (US$ Billion)
Figure 39: Europe Biologics Market by Value; 2016-2017 (US$ Billion)
Figure 40: Europe Biologics Market by Value; 2018-2022E (US$ Billion)
Figure 41: China Biologics Market by Value; 2012-2017 (US$ Billion)
Figure 42: China Biologics Market by Value; 2018-2022E (US$ Billion)
Figure 43: FDA Approved Medicines in US; 2010-2016
Figure 44: Prevalence of Diagnosed Autoimmune Conditions; 2016
Figure 45: Global Biopharmaceuticals (Drugs) Market by Segments; 2006-2020
Figure 46: Abbvie Inc. and Humira Sales; 2102-2016 (US$ Billion)
Figure 47: Abbvie Inc. Sales by Geography; 2016
Figure 48: Samsung Electronics Segments Overview
Figure 49: Samsung Electronics Ownership Structure
Figure 50: Samsung Electronics and Biologics Revenue; 2012-2016 (US$ Billion)
Figure 51: Samsung Electronics Revenue by Segments; 2016
Figure 52: F. Hoffmann-La Roche Sales; 2015-2017 (US$ Billion)
Figure 53: F. Hoffmann-La Roche Sales by Segments; 2017
Figure 54: Amgen Inc. and ENBREL Sales; 2012-2016 (US$ Billion)
Figure 55: Amgen Inc. Sales by Products; 2016
Figure 56: ENBREL Sales by Geography; 2016
Table 1: Chemical Drugs vs. Biologics
Table 2: Key Biologics Product US/EU Expiry Date
Table 3: Major Biologics Patent Expiration between 2015-2025E
Table 4: Current Pharmaceutical Research & Development Pipeline Trends; 2016
Table 5: Global Blockbuster Biologics Pipeline; 2017
Table 6: Global Biologics Market by Players/Drugs; 2016
Table 7: HUMIRA Principal Markets
Table 8: Abbvie Inc. Sales by Products; 2016